Tryton Medical Lands $20,000,000 New Financing

  • Feed Type
  • Date
    9/8/2014
  • Company Name
    Tryton Medical
  • Mailing Address
    1000 Park Forty Plaza Durham, NC 27713 USA
  • Company Description
    Tryton Medical, Inc. is the leading developer of stents that are designed to definitively treat bifurcation lesions. 540,000 bifurcation coronary lesions are sub-optimally treated every year with a variety of time consuming and technically challenging procedures.
  • Website
    http://www.trytonmedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The Company will use these proceeds to complete enrollment in the Tryton IDE Extended Access Registry, to support our U.S. Food and Drug Administration (FDA) submission, and to develop the left main market opportunity with the CE approved left main stent indication for our Tryton Side Branch Stent.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy